Literature DB >> 18785969

Information needs in parents of children with a rheumatic disease.

A Thon1, G Ullrich.   

Abstract

BACKGROUND AND
OBJECTIVE: Incorporating the patient's perspective and expectations into the delivery of health care has become an important indicator of today's quality of medical care. Our aim was consequently to explore the information needs of parents of children with juvenile idiopathic arthritis and other rheumatic diseases.
MATERIALS AND METHODS: Cross-sectional, anonymous survey using a purpose-designed questionnaire, which separately assessed sources of information and topics. With respect to sources, we also asked about their degree of helpfulness, and regarding topics, we also asked about further interests (information needs). The questionnaire was sent to 146 families continuously attending our paediatric rheumatology outpatient clinic. The response rate was 79.5%. The mean age of the children was 6.9 +/- 4.3 years, 69% were girls and disease duration averaged 2.6 +/- 4.3 years. Mean Child Health Assessment Questionnaire score as a measure of functional disability was 0.259 (+/-0.45; range 0.0-2.13).
RESULTS: Regarding sources, those with a professional medical background were appreciated, while information from friends and family members, in particular, was not. Overall, parents considered themselves well-informed. Parents had frequently received information on core domains of medical aspects. They described deficits related to psychosocial impact, to (vocational) education and to complementary therapy. However, their interest in further information was high almost irrespective of the amount of prior information.
CONCLUSION: For further tailored information and support strategies it should be taken into account that even for topics largely covered by usual medical advice, residual interest and information needs of parents remain high.

Entities:  

Mesh:

Year:  2008        PMID: 18785969     DOI: 10.1111/j.1365-2214.2008.00870.x

Source DB:  PubMed          Journal:  Child Care Health Dev        ISSN: 0305-1862            Impact factor:   2.508


  7 in total

1.  Struggling in the Dark to Help My Child: Parents' Experience in Caring for a Young Child with Juvenile Idiopathic Arthritis.

Authors:  Weichao Yuwen; Frances M Lewis; Amy J Walker; Teresa M Ward
Journal:  J Pediatr Nurs       Date:  2017-08-01       Impact factor: 2.145

Review 2.  The place of pediatric rheumatology in India.

Authors:  Sujata Sawhney; Prudence Manners
Journal:  Indian J Pediatr       Date:  2010-09-03       Impact factor: 1.967

Review 3.  Studies analysing the need for health-related information in Germany - a systematic review.

Authors:  Dawid Pieper; Fabian Jülich; Sunya-Lee Antoine; Christina Bächle; Nadja Chernyak; Jutta Genz; Michaela Eikermann; Andrea Icks
Journal:  BMC Health Serv Res       Date:  2015-09-23       Impact factor: 2.655

4.  An evaluation of a juvenile idiopathic arthritis retreat for families.

Authors:  Michelle L Burbage; Meredith B Mason; Laura A Nabors; Jessica C Kichler
Journal:  Pediatr Rheumatol Online J       Date:  2015-04-21       Impact factor: 3.054

5.  Parents' information needs and influential factors when making decisions about TNF-α inhibitors.

Authors:  Ellen A Lipstein; Daniel J Lovell; Lee A Denson; Sandra C Kim; Charles Spencer; Maria T Britto
Journal:  Pediatr Rheumatol Online J       Date:  2016-09-15       Impact factor: 3.054

6.  The information needs of people living with ankylosing spondylitis: a questionnaire survey.

Authors:  Roxanne Cooksey; Sinead Brophy; Muhammad Jami Husain; Elizabeth Irvine; Helen Davies; Stefan Siebert
Journal:  BMC Musculoskelet Disord       Date:  2012-12-10       Impact factor: 2.362

7.  Impact of a telenursing service on satisfaction and health outcomes of children with inflammatory rheumatic diseases and their families: a crossover randomized trial study protocol.

Authors:  Anne-Sylvie Ramelet; Béatrice Fonjallaz; Joachim Rapin; Christophe Gueniat; Michaël Hofer
Journal:  BMC Pediatr       Date:  2014-06-18       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.